Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

A Study Evaluating Ficerafusp Alfa (BCA101) QW in Combination With Pembrolizumab vs Alternative Ficerafusp Alfa Dosing in 1L R or M HNSCC

Bicara Therapeutics · 2026
ClinicalTrials.gov · Datasets · License: Public Domain · 2026
Open Source ↗
head-and-neck-cancerpembrolizumab
metastatic head and neck squamous cell carcinoma, recurrent head and neck squamous cell carcinoma, head and neck cancer, hnscc, recurrent hnscc, metastatic hnscc, first line treatment, phase 2, pembrolizumab, pd-l1+, tgf-beta, oral cavity
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗
Record · ID 889697
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.